Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Integrated multi-omics data analysis identifies a novel genetics-risk gene of IRF4 associated with prognosis of oral cavity cancer

Yan Lv, Yukuang Huang, Xuejun Xu, Zhiwei Wang, Yanfang Yu, Yunlong Ma, Mengjie Wu
doi: https://doi.org/10.1101/2021.11.17.21266500
Yan Lv
1The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukuang Huang
2Institute of Biomedical Big Data, School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, 325027, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuejun Xu
1The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhiwei Wang
1The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanfang Yu
1The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunlong Ma
2Institute of Biomedical Big Data, School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, 325027, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glb-biotech@zju.edu.cn wumengjie@zju.edu.cn
Mengjie Wu
1The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glb-biotech@zju.edu.cn wumengjie@zju.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Oral cavity cancer (OCC) is one of the most common carcinoma diseases. Recent genome-wide association studies (GWAS) have reported numerous genetic variants associated with OCC susceptibility. However, the regulatory mechanisms of these genetic variants underlying OCC remain largely unclear.

Objective This study aimed to identify OCC-related genetics risk genes contributing to the prognosis of OCC.

Methods By combining GWAS summary statistics (N = 4,151) with expression quantitative trait loci (eQTL) across 49 different tissues from the GTEx database, we performed an integrative genomics analysis to uncover novel risk genes associated with OCC. By leveraging various computational methods based on multi-omics data, risk genes were prioritized as promising candidate genes for drug repurposing in OCC.

Results Using two independent computational algorithms, we found that 14 risk genes whose genetics-modulated expressions showed a notable association with OCC. Among them, nine genes were newly identified, such as IRF4 (P = 2.5×10-9 and P = 1.06×10-4), TNS3 (P = 1.44×10-6 and P = 4.45×10-3), ZFP90 (P = 2.37×10-6 and P = 2.93×10-4), and DRD2 (P = 2.0×10-5 and P = 6.12×10-3).

These 14 genes were significantly overrepresented in several cancer-related terms, and 10 of 14 genes were enriched in 10 potential druggable gene categories. Based on differential gene expression analysis, the majority of these genes (71.43%) showed remarkable differential expressions between OCC patients and paracancerous controls. Integration of multi-omics-based evidence from genetics, eQTL, and gene expression, we identified that the novel risk gene of IRF4 exhibited the highest ranked risk score for OCC. Survival analysis showed that dysregulation of IRF4 expression was significantly associated with cancer patients outcomes (P = 8.1×10-5).

Conclusions In summary, we prioritized 14 OCC-associated genes with nine novel risk genes, especially the IRF4 gene, which provides a drug repurposing resource to develop therapeutic drugs for oral cancer.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported by National Natural Science Foundation of China (No. 81970956 to M.W.), and the Scientific Research Foundation for Talents of Wenzhou Medical University (KYQD20201001 to Y.M.). The funders had no role in the designing and conducting of this study and collection, analysis, and interpretation of data and in writing the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

https://gwas.mrcieu.ac.uk/

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the GWAS summary statistics on oral cancer applied in the present analysis can be obtained from the MRC Integrative Epidemiology Unit (IEU) database (https://gwas.mrcieu.ac.uk/, accession ID: ieu-b-94). The GTEx eQTL data (version 8) were gained from the Zenodo repository (https://zenodo.org/record/3518299#.Xv6Z6igzbgl). The 1,000 Genomes Project European Phase 3 reference panel was downloaded from the IGSR: The International Genome Sample Resource (https://www.internationalgenome.org/category/phase-3/).

https://gwas.mrcieu.ac.uk/,

  • Abbreviations

    OCC
    Oral cavity cancer
    GWAS
    Genome-wide association study
    eQTL
    expression quantitative loci trait
    sQTL
    splicing quantitative loci trait
    SNP
    Single nucleotide polymorphism
    CC
    Cellular component
    MF
    Molecular function
    BP
    Biological process
    IEU
    Integrative Epidemiology Unit
    INHANCE
    International Head and Neck Cancer Epidemiology Consortium
    OR
    Odds ratio
    MAGMA
    the Multi-marker Analysis of GenoMic Annotation
    LD
    Linkage disequilibrium
    FDR
    False discovery rate
    WebGestalt
    WEB-based Gene SeT AnaLysis Toolkit
    GO
    Gene Ontology
    PPI
    Protein-protein interaction
    GEO
    the database of Gene Expression Omnibus
    TCGA
    The Cancer Genome Atlas.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 21, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Integrated multi-omics data analysis identifies a novel genetics-risk gene of IRF4 associated with prognosis of oral cavity cancer
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Integrated multi-omics data analysis identifies a novel genetics-risk gene of IRF4 associated with prognosis of oral cavity cancer
    Yan Lv, Yukuang Huang, Xuejun Xu, Zhiwei Wang, Yanfang Yu, Yunlong Ma, Mengjie Wu
    medRxiv 2021.11.17.21266500; doi: https://doi.org/10.1101/2021.11.17.21266500
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Integrated multi-omics data analysis identifies a novel genetics-risk gene of IRF4 associated with prognosis of oral cavity cancer
    Yan Lv, Yukuang Huang, Xuejun Xu, Zhiwei Wang, Yanfang Yu, Yunlong Ma, Mengjie Wu
    medRxiv 2021.11.17.21266500; doi: https://doi.org/10.1101/2021.11.17.21266500

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Genetic and Genomic Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (174)
    • Allergy and Immunology (421)
    • Anesthesia (97)
    • Cardiovascular Medicine (901)
    • Dentistry and Oral Medicine (170)
    • Dermatology (102)
    • Emergency Medicine (257)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
    • Epidemiology (8783)
    • Forensic Medicine (4)
    • Gastroenterology (405)
    • Genetic and Genomic Medicine (1861)
    • Geriatric Medicine (178)
    • Health Economics (388)
    • Health Informatics (1290)
    • Health Policy (644)
    • Health Systems and Quality Improvement (491)
    • Hematology (207)
    • HIV/AIDS (393)
    • Infectious Diseases (except HIV/AIDS) (10557)
    • Intensive Care and Critical Care Medicine (564)
    • Medical Education (193)
    • Medical Ethics (52)
    • Nephrology (218)
    • Neurology (1754)
    • Nursing (103)
    • Nutrition (266)
    • Obstetrics and Gynecology (342)
    • Occupational and Environmental Health (461)
    • Oncology (964)
    • Ophthalmology (282)
    • Orthopedics (107)
    • Otolaryngology (176)
    • Pain Medicine (117)
    • Palliative Medicine (43)
    • Pathology (264)
    • Pediatrics (557)
    • Pharmacology and Therapeutics (264)
    • Primary Care Research (219)
    • Psychiatry and Clinical Psychology (1843)
    • Public and Global Health (3982)
    • Radiology and Imaging (654)
    • Rehabilitation Medicine and Physical Therapy (344)
    • Respiratory Medicine (535)
    • Rheumatology (215)
    • Sexual and Reproductive Health (178)
    • Sports Medicine (166)
    • Surgery (197)
    • Toxicology (37)
    • Transplantation (106)
    • Urology (80)